Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

Risk Factors for Aggravation of Myopic Retinoschisis after Intravitreal Bevacizumab Injection in Myopic Choroidal Neovascularization: Ji Yoon Song, Jong Min Kim; J Korean Ophthalmol Soc. 2024;65(5):328-336. Published online May 14, 2024; DOI: https://doi.org/10.3341/jkos.2024.65.5.328; Full text PubReader ePub PDF

Comparison between Focal Laser Photocoagulation and Intravitreal Bevacizumab Injection for Treating Chronic Central Serous Chorioretinopathy: Young Bin Yoon, Woo Seok Choi, Kyoo Won Lee, Dong-Geun Park; J Korean Ophthalmol Soc. 2024;65(4):277-284. Published online April 12, 2024; DOI: https://doi.org/10.3341/jkos.2024.65.4.277; Full text PubReader ePub PDF

Case Reports

An Adolescent Case of Unilateral Papillophlebitis Treated with Intravitreal Bevacizumab: Bo Kang Seo, Jaehyuk Lee, Jihae Park; J Korean Ophthalmol Soc. 2024;65(2):167-171. Published online February 15, 2024; DOI: https://doi.org/10.3341/jkos.2024.65.2.167; Full text PubReader ePub PDF

Original Articles

Comparison of Intravitreal Bevacizumab and Ranibizumab Injections in Aggressive and Type 1 Retinopathy of Prematurity: Kyumin Kang, Ji Hye Jang; J Korean Ophthalmol Soc. 2023;64(9):784-792. Published online September 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.9.784; Full text PubReader ePub PDF

Effects of Subconjunctival Bevacizumab Injection after Primary Pterygium Surgery: Eunyu Yoon, Minji Park, Jaewon Choi; J Korean Ophthalmol Soc. 2023;64(8):688-693. Published online August 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.8.688; Full text PubReader ePub PDF

A Comparison between Intravitreal Bevacizumab Injection and Placement of a Dexamethasone Implant to Treat Retinal Vein Occlusion Macular Edema: Hyeong Ju Kim, Jung Kee Min; J Korean Ophthalmol Soc. 2023;64(3):204-213. Published online March 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.3.204; Full text PubReader ePub PDF

Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept: Daeun Shin, Jae Hui Kim; J Korean Ophthalmol Soc. 2022;63(6):526-534. Published online June 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.6.526
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Case Reports

A Case of Iris Neovascularization in Severe Fungal Keratitis Treated with Intracameral Bevacizumab: Yeon Ju Lim, Chan-Ho Cho; J Korean Ophthalmol Soc. 2022;63(5):472-477. Published online May 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.5.472; Full text PubReader ePub PDF

Original Articles

Predictors of Dexamethasone Response of Residual Edema by Branch Retinal Vein Occlusion after Bevacizumab Injection: Jong Bin Lee, Hyun Yeon Kim, Yun Young Kim, Geun Woo Lee; J Korean Ophthalmol Soc. 2022;63(4):370-379. Published online April 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.4.370; Full text PubReader ePub PDF

Case Reports

A Rare Case of Breast Cancer Metastasis to the Optic Nerve Head: Jae Won Jun, Dong Hyun Lee, Minwoo Lee, Eun Young Choi, Min Kim; J Korean Ophthalmol Soc. 2022;63(3):320-324. Published online March 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.3.320
Web of Science 1; Full text PubReader ePub PDF

Original Articles

Treatment Results of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion: Yu-Jin Choi, Young Je Choi, Yong Wun Cho, Woong-Sun Yoo, In Young Chung; J Korean Ophthalmol Soc. 2021;62(9):1207-1217. Published online September 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.9.1207; Full text PubReader ePub PDF

Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration: Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(8):1076-1083. Published online August 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.8.1076
Web of Science 3 Crossref 5; Full text PubReader ePub PDF

Combined Intravitreal Bevacizumab and Laser Photocoagulation to Treat Retinal Arterial Macroaneurysms: Tae Hoon Kim, Chang Zoo Kim, Seung Uk Lee, Sang Joon Lee; J Korean Ophthalmol Soc. 2021;62(8):1053-1060. Published online August 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.8.1053
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Effect of Anti-vascular Endothelial Growth Factor on the Matrix Metalloproteinase Activity in Trabecular Meshwork Cells: Hyeon Jin Park, Jeong Wook Shin, Jae Woo Kim; J Korean Ophthalmol Soc. 2021;62(7):976-982. Published online July 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.7.976; Full text PubReader ePub PDF

Comparison of Intravitreal Bevacizumab and Aflibercept Injections for Central Serous Chorioretinopathy: Min Soo Park, Seung Joon Lee; J Korean Ophthalmol Soc. 2021;62(7):957-962. Published online July 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.7.957
Crossref 1; Full text PubReader ePub PDF

Volume 67, No. 5

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

Impact Factor

0.1

MOST VIEWED MOST CITED

6,409	Self-assessment of Visual Acuity Using a Smartphone Application
4,515	Accuracy of Intraocular Lens Power Prediction Using 9 Formula
2,986	Central Anticholinergic Syndrome Induced by Atropine Eye Drops: A Case Report
1,665	Efficacy of 1% Ivermectin Ointment for Demodex Blepharitis
3,185	Short-term Outcomes of Ranibizumab Biosimilar CKD-701 Treatment in Macular Edema Secondary to Retinal Vein Occlusion

Cited By 4	The Effect of Topical Rebamipide 2% in Managing Dry Eye Following Cataract Surgery
Cited By 3	A Case of Retinal Vasculitis, Uveitis in Myelin Oligodendrocyte Glycoprotein Antibody Associated Optic Neuritis
Cited By 2	What Laboratory Examinations for Open-angle Glaucoma Risk Stratification
Cited By 2	Comparison of Clinical Outcomes Among Sutured, Sutureless Scleral Fixation, and Retropupillary Fixation of Intraocular Lens
Cited By 2	Short-term Outcomes of Ranibizumab Biosimilar CKD-701 Treatment in Macular Edema Secondary to Retinal Vein Occlusion

Editorial Office: #1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6603 Fax: +82-2-2277-5194 E-mail: kos@ijpnc.com

Copyright © 2026 by Korean Ophthalmological Society.

prev

next